Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorHangzhou Tangji Medical Technology Co., Ltd.

About this trial

Evaluate the preliminary effectiveness and safety of the Gastric Bypass Stent System in treating nonalcoholic fatty liver disease.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Gastric Bypass Stent System in Treatment of Patients with Nonalcoholic Fatty Liver Disease

Treatment groups

10 Participants
are divided into 1 treatment group